9999999997-17-010069.txt : 20171128 9999999997-17-010069.hdr.sgml : 20171128 20171128124901 ACCESSION NUMBER: 9999999997-17-010069 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20171128 DATE AS OF CHANGE: 20171128 ACTION DATE: 20171127 RECEIVED DATE: 20171128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dare Bioscience, Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-36395 FILM NUMBER: 171224879 BUSINESS ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-769-9145 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Cerulean Pharma Inc. DATE OF NAME CHANGE: 20090714 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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